Rome, Italy, 9/2/08 -- Fondazione Parco Biomedico San Raffaele (www.scienceparkrome.org), is pleased to announce the cooperation achievement with the Zangani Investor Community (www.zangani.com). Zangani will advise the company in strategic business development within the United States.

Dr. Domenico Pecorini COO of the Fondazione Parco Scientifico San Raffaele di Roma, commented, "We are very excited about bringing Zangani on board at this critical juncture in our corporate history. We expect that their experience and expertise will enable us to meet and exceed our corporate objectives. Not only does the Zangani Investor Community have an excellent reputation, but they also have a firm grasp of market dynamics and a thorough understanding of domestic and international business development strategies."

About Fondazione Parco Biomedico San Raffaele:

Located approximately 15 km south of Rome in a natural reserve, the science park was created by the Banca di Roma now part of Unicredit Group, the Chamber of Commerce of Rome, and the Fondazione San Raffaele Monte Tabor in response to the recognized need to have a biomedical research centre in the Lazio region. Opened in 2002, the park is now home to 2 companies and 9 research groups from Universities and centers working in: Oncology, leukemia and Immunology; Molecular cardiology; Skeletal regeneration; Cell therapy and tissue engineering; Muscular dystrophies; Biomedical quality control; Neurological Disorders; Stem cells; and Diabetes.

Contact:

Zangani Investor Community
Investor Relations
(908) 788-9660
office@zangani.com
www.zangani.com